KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Assets (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Non-Current Assets for 8 consecutive years, with $212.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 16.85% to $212.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $910.9 million through Dec 2025, down 7.56% year-over-year, with the annual reading at $212.6 million for FY2025, 16.85% down from the prior year.
  • Non-Current Assets hit $212.6 million in Q4 2025 for Adaptive Biotechnologies, up from $209.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $525.6 million in Q3 2021 to a low of $209.2 million in Q3 2025.
  • Historically, Non-Current Assets has averaged $308.6 million across 5 years, with a median of $285.1 million in 2023.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 140.96% in 2021 and later tumbled 43.44% in 2022.
  • Year by year, Non-Current Assets stood at $520.6 million in 2021, then crashed by 43.44% to $294.5 million in 2022, then decreased by 14.78% to $250.9 million in 2023, then increased by 1.86% to $255.6 million in 2024, then decreased by 16.85% to $212.6 million in 2025.
  • Business Quant data shows Non-Current Assets for ADPT at $212.6 million in Q4 2025, $209.2 million in Q3 2025, and $234.8 million in Q2 2025.